Moreover, hepatocellular carcinoma cells with high levels of YAP expression were doxorubicin-resistant, and hyper-activation of YAP was observed in 5-fluorouracil (5-FU)-resistant colon cancer cells and castration-resistant prostate tumor samples [16–18]. Here, YAP1 is linked to malignant colon neoplasm.